Department of Pharmacology, College of Pharmacy, Chonnam National University, Gwangju, 61186, Republic of Korea.
College of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, Guizhou, China.
Cell Commun Signal. 2023 Jan 19;21(1):11. doi: 10.1186/s12964-022-01013-z.
Desensitization of G protein-coupled receptors (GPCRs) refers to a rapid attenuation of responsiveness that occurs with repeated or continuous exposure to agonists. GRK-mediated phosphorylation and subsequent binding with arrestins in the activated receptor cytoplasmic cavity in competition with G proteins has been suggested as the conventional mechanism of desensitization. Along with widely accepted conventional mechanism of desensitization, studies of various GPCRs including dopamine D2-like receptors (DR, DR, DR) have suggested the existence of another desensitization mechanism. In this study, loss-of-function approaches and D2-like receptor mutants that display different desensitization properties were used to elucidate the molecular mechanisms responsible for desensitization.
Desensitization development entailed the signaling cascade composed of Src, PDK1, and Akt, the latter of which in turn interacted with USP33, an arrestin deubiquitinase, to promote arrestin deubiquitination. The deubiquitinated arrestin subsequently formed a complex with Gβγ and translocated to the nucleus via an importin complex, wherein it sequestered Gβγ from the receptor and Gα, thereby attenuating receptor signaling. As in D2-like receptors, both USP33 and importin β1 were involved in the desensitization of the β adrenoceptor.
In addition to the conventional mechanism of desensitization, which occurs on the plasma membrane and in the cytosol, this study provides a new insight that another desensitization pathway in which nuclear trafficking plays a critical role is operating. It is plausible that multiple, complementary desensitization measures are in place to properly induce desensitization depending on receptor characteristics or the surrounding environment. Video Abstract.
G 蛋白偶联受体 (GPCR) 的脱敏是指在反复或连续暴露于激动剂时,受体对激动剂的反应迅速减弱。GRK 介导的磷酸化以及随后与激活的受体细胞溶质腔中的内陷素结合,与 G 蛋白竞争,被认为是脱敏的传统机制。除了广泛接受的脱敏传统机制外,对多巴胺 D2 样受体 (DR、DR、DR) 等各种 GPCR 的研究表明,还存在另一种脱敏机制。在这项研究中,使用了功能丧失方法和显示不同脱敏特性的 D2 样受体突变体,以阐明负责脱敏的分子机制。
脱敏的发展涉及由Src、PDK1 和 Akt 组成的信号级联反应,后者反过来与 USP33 相互作用,USP33 是一种内陷素去泛素化酶,可促进内陷素去泛素化。去泛素化的内陷素随后与 Gβγ 形成复合物,并通过导入复合物转移到细胞核,其中它将 Gβγ 从受体和 Gα 中隔离出来,从而减弱受体信号。与 D2 样受体一样,USP33 和导入素 β1 都参与了β肾上腺素受体的脱敏。
除了发生在质膜和细胞质中的传统脱敏机制外,本研究提供了一个新的见解,即另一种脱敏途径,其中核转运起关键作用,正在起作用。根据受体的特征或周围环境,可能存在多种互补的脱敏措施来正确诱导脱敏。视频摘要。